Koen Degeling

492 total citations
35 papers, 310 citations indexed

About

Koen Degeling is a scholar working on Economics and Econometrics, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Koen Degeling has authored 35 papers receiving a total of 310 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Economics and Econometrics, 12 papers in Oncology and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Koen Degeling's work include Health Systems, Economic Evaluations, Quality of Life (13 papers), Colorectal Cancer Treatments and Studies (8 papers) and Economic and Financial Impacts of Cancer (8 papers). Koen Degeling is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (13 papers), Colorectal Cancer Treatments and Studies (8 papers) and Economic and Financial Impacts of Cancer (8 papers). Koen Degeling collaborates with scholars based in Australia, Netherlands and United States. Koen Degeling's co-authors include Maarten J. IJzerman, Hendrik Koffijberg, Miriam Koopman, Peter Gibbs, Fanny Franchini, Benjamin Solomon, G. Bruce Mann, Jeanne Tie, Jon Emery and Grant A. McArthur and has published in prestigious journals such as Journal of Clinical Oncology, Frontiers in Pharmacology and BMC Medical Research Methodology.

In The Last Decade

Koen Degeling

33 papers receiving 308 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Koen Degeling Australia	10	125	104	79	65	38	35	310
Ewan Gray United Kingdom	11	170 1.4×	124 1.2×	59 0.7×	47 0.7×	76 2.0×	30	419
Abiola Ibraheem United States	11	140 1.1×	68 0.7×	142 1.8×	123 1.9×	13 0.3×	26	364
Victoria Kaestner United States	6	156 1.2×	46 0.4×	49 0.6×	58 0.9×	34 0.9×	7	308
A.L. Vataire France	13	157 1.3×	114 1.1×	158 2.0×	170 2.6×	22 0.6×	34	478
E.C. Faulkner United States	9	153 1.2×	135 1.3×	76 1.0×	77 1.2×	17 0.4×	20	500
Saskia de Groot Netherlands	12	114 0.9×	171 1.6×	24 0.3×	109 1.7×	27 0.7×	35	440
Gwynn Ison United States	9	216 1.7×	88 0.8×	102 1.3×	90 1.4×	10 0.3×	16	439
K. J. Pandya United States	8	175 1.4×	46 0.4×	77 1.0×	69 1.1×	47 1.2×	26	344
Mathias Lidgren Sweden	7	241 1.9×	209 2.0×	123 1.6×	44 0.7×	33 0.9×	12	442
Shanthi Sivendran United States	11	167 1.3×	41 0.4×	30 0.4×	83 1.3×	20 0.5×	28	410

Countries citing papers authored by Koen Degeling

Since Specialization

Citations

This map shows the geographic impact of Koen Degeling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Koen Degeling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Koen Degeling more than expected).

Fields of papers citing papers by Koen Degeling

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Koen Degeling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Koen Degeling. The network helps show where Koen Degeling may publish in the future.

Co-authorship network of co-authors of Koen Degeling

This figure shows the co-authorship network connecting the top 25 collaborators of Koen Degeling. A scholar is included among the top collaborators of Koen Degeling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Koen Degeling. Koen Degeling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Degeling, Koen, et al.. (2025). Discrete Event Simulation in R using the ‘Simmer’ Package for Health Economic Modelling: A Tutorial and Illustration in Colon Cancer. Applied Health Economics and Health Policy. 23(6). 961–975. 1 indexed citations

Smith, Hadley Stevens, Dean A. Regier, Ilias Goranitis, et al.. (2025). Approaches to Incorporation of Preferences into Health Economic Models of Genomic Medicine: A Critical Interpretive Synthesis and Conceptual Framework. Applied Health Economics and Health Policy. 23(3). 337–358. 2 indexed citations

Bond, Marinde J. G., Maarten van Smeden, Koen Degeling, et al.. (2024). Predicting Benefit From FOLFOXIRI Plus Bevacizumab in Patients With Metastatic Colorectal Cancer. JCO Clinical Cancer Informatics. 8(8). e2400037–e2400037. 2 indexed citations

Schneider, G, et al.. (2023). Quantifying the impact of novel metastatic cancer therapies on health inequalities in survival outcomes. Frontiers in Pharmacology. 14. 1249998–1249998. 2 indexed citations

Gibbs, Peter, et al.. (2023). Circulating Tumour DNA Guided Adjuvant Chemotherapy Decision Making in Stage II Colon Cancer—A Clinical Vignette Study. Cancers. 15(21). 5227–5227. 2 indexed citations

Gibbs, Peter, et al.. (2023). Health economic evidence for adjuvant chemotherapy in stage II and III colon cancer: a systematic review. Cost Effectiveness and Resource Allocation. 21(1). 11–11. 2 indexed citations

Degeling, Koen, et al.. (2023). Cost Effectiveness of Molecular Diagnostic Testing Algorithms for the Treatment Selection of Frontline Ibrutinib for Patients with Chronic Lymphocytic Leukemia in Australia. Applied Health Economics and Health Policy. 22(1). 107–122. 1 indexed citations

Franchini, Fanny, et al.. (2023). Implementing competing risks in discrete event simulation: the event-specific probabilities and distributions approach. Frontiers in Pharmacology. 14. 1255021–1255021. 1 indexed citations

Koole, Simone N., Robert D. Schouten, Koen Degeling, et al.. (2022). Cell-Free DNA at Diagnosis for Stage IV Non-Small Cell Lung Cancer: Costs, Time to Diagnosis and Clinical Relevance. Cancers. 14(7). 1783–1783. 5 indexed citations

10.

Degeling, Koen, Fanny Franchini, Ben Tran, et al.. (2022). Comparing Survival Outcomes for Advanced Cancer Patients Who Received Complex Genomic Profiling Using a Synthetic Control Arm. Targeted Oncology. 17(5). 539–548. 10 indexed citations

11.

Degeling, Koen, Nancy N. Baxter, Jon Emery, et al.. (2021). An inverse stage‐shift model to estimate the excess mortality and health economic impact of delayed access to cancer services due to the COVID‐19 pandemic. Asia-Pacific Journal of Clinical Oncology. 17(4). 359–367. 56 indexed citations

12.

Degeling, Koen, Hui‐Li Wong, Hendrik Koffijberg, et al.. (2020). Simulating Progression-Free and Overall Survival for First-Line Doublet Chemotherapy With or Without Bevacizumab in Metastatic Colorectal Cancer Patients Based on Real-World Registry Data. PharmacoEconomics. 38(11). 1263–1275. 3 indexed citations

13.

Koffijberg, Hendrik, Koen Degeling, Maarten J. IJzerman, Veerle M.H. Coupé, & Marjolein J.E. Greuter. (2020). Using Metamodeling to Identify the Optimal Strategy for Colorectal Cancer Screening. Value in Health. 24(2). 206–215. 8 indexed citations

14.

Hond, Anne de, Koen Degeling, Cornelis J.A. Punt, et al.. (2020). Evaluation of the performance of algorithms mapping EORTC QLQ-C30 onto the EQ-5D index in a metastatic colorectal cancer cost-effectiveness model. Health and Quality of Life Outcomes. 18(1). 240–240. 4 indexed citations

15.

Degeling, Koen, Hendrik Koffijberg, Hui‐Li Wong, et al.. (2020). Health Economic Models for Metastatic Colorectal Cancer: A Methodological Review. PharmacoEconomics. 38(7). 683–713. 15 indexed citations

16.

Degeling, Koen, et al.. (2018). Comparing Strategies for Modeling Competing Risks in Discrete-Event Simulations: A Simulation Study and Illustration in Colorectal Cancer. Medical Decision Making. 39(1). 57–73. 15 indexed citations

17.

Degeling, Koen, Anne M. May, Martijn G.H. van Oijen, et al.. (2018). Matching the model with the evidence: comparing discrete event simulation and state-transition modeling for time-to-event predictions in a cost-effectiveness analysis of treatment in metastatic colorectal cancer patients. Cancer Epidemiology. 57. 60–67. 20 indexed citations

18.

Degeling, Koen, Niven Mehra, Hendrik Koffijberg, et al.. (2017). Comparison of Timed Automata with Discrete Event Simulation for Modeling of Biomarker-Based Treatment Decisions: An Illustration for Metastatic Castration-Resistant Prostate Cancer. Value in Health. 20(10). 1411–1419. 8 indexed citations

19.

Degeling, Koen, Hendrik Koffijberg, & Maarten J. IJzerman. (2016). A systematic review and checklist presenting the main challenges for health economic modeling in personalized medicine: towards implementing patient-level models. Expert Review of Pharmacoeconomics & Outcomes Research. 17(1). 17–25. 28 indexed citations

20.

Degeling, Koen, et al.. (2015). Timed Automata Modeling of The Personalized Treatment Decisions In Metastatic Castration Resistant Prostate Cancer. Value in Health. 18(7). A702–A703. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact